Beck, Juliane <br/><br/>
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Dec 2017 
 - 2545-2553 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-017-2504-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bendamustine Hydrochloride--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lenalidomide<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Prednisolone--administration & dosage<br/>Prospective Studies<br/>Thalidomide--administration & dosage